SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Klauninger, R
Right arrow Articles by Wahren-Herlenius, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klauninger, R
Right arrow Articles by Wahren-Herlenius, M
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

research-article

Serologic follow-up of children born to mothers with Ro/SSA autoantibodies

R Klauninger

Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

A Skog

Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

L Horvath

Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

O Winqvist

Clinical Immunology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

A Edner

Department of Women and Child Health, Karolinska Institutet, Stockholm, Sweden

K Bremme

Department of Women and Child Health, Karolinska Institutet, Stockholm, Sweden

SE Sonesson

Department of Women and Child Health, Karolinska Institutet, Stockholm, Sweden

M Wahren-Herlenius

Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, SwedenMarie.Wahren{at}ki.se

Neonatal lupus erythematosus (NLE) develops in foetuses of mothers with Ro/SSA and La/SSB antibodies and may include foetal atrioventricular block and dermatologic manifestations. In this study, we investigated postnatal Ro and La IgG, IgA and IgM antibody levels up to 1 year of age in 32 children born to Ro/SSA positive mothers. Antibody levels were correlated with NLE manifestations, and the role of breast feeding in transfer of autoantibodies from mother to child was evaluated. Ro52, Ro60 and La IgG antibodies all transferred from the mothers to their foetus in utero and were present in the infant at birth as detected by enzyme-linked immunosorbent assay using recombinant antigens and a synthetic peptide. A significant decrease in Ro52, Ro60 and La IgG autoantibody levels of the infants was observed from birth to 4–5 weeks of age (P < 0.05, P < 0.05 and P < 0.01). Ro- and La-specific IgA and IgM antibodies were detected in the serum from a subset of mothers. However, Ro- and La-specific IgA and IgM antibody levels were low or non-detectable in children raised both with and without breastfeeding. Furthermore, NLE skin lesions developed independently of breastfeeding. Our findings support a role for placental materno-foetal transfer of IgG autoantibodies in the pathogenesis of NLE and indicate that refraining from breastfeeding does not protect from NLE skin involvement.

Key Words: congenital heart block • neonatal lupus • Ro52 • SSA

Lupus, Vol. 18, No. 9, 792-798 (2009)
DOI: 10.1177/0961203309103188


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement